10-Q: Beyond Meat Reports Q1 2026 Results, Revenue Declines
Quarterly Report
Beyond Meat's Q1 2026 filing reveals a 15.3% year-over-year revenue decrease to $58.2 million, alongside a narrowed net loss.
Summary
- Beyond Meat reported net revenues of $58.2 million for the three months ended March 28, 2026, a decrease of 15.3% compared to $68.7 million in the prior year period.
- The company experienced a net loss of $28.5 million, an improvement from the $61.1 million net loss in the same period last year.
- Cost of goods sold decreased by 25.7% to $56.2 million, primarily due to lower sales volumes.
- Gross profit improved to $2.0 million from a gross loss of $6.9 million in the prior year.
- Operating expenses were reduced, with R&D expenses down 30.0% and SG&A expenses down 24.2%.
- The company is continuing its strategic repositioning to 'Beyond The Plant Protein Company' and has launched its Beyond Immerse beverage line.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as negative due to the significant revenue decline and continued operating losses, although there are some positives in gross margin improvement and expense reduction.
Positives
- Gross profit improved significantly to $2.0 million from a gross loss of $6.9 million in the prior year.
- Gross margin improved to 3.4% from -10.1% in the prior year.
- Net loss narrowed to $28.5 million from $61.1 million in the prior year.
- Operating expenses were reduced across R&D and SG&A, indicating cost control measures.
- The company is actively pursuing a strategic repositioning and product line expansion with the launch of Beyond Immerse.
Negatives
- Net revenues decreased by 15.3% to $58.2 million, driven by a 19.5% decrease in volume sold.
- U.S. retail and foodservice revenues saw significant declines of 15.3% and 29.7%, respectively.
- International foodservice revenues also declined by 25.9%.
- The company continues to operate at a loss and has a history of negative cash flows from operating activities.
- The company is still subject to material weaknesses in internal control over financial reporting.
Risks
- The strategic repositioning to 'Beyond The Plant Protein Company' may not be successful, potentially leading to brand dilution or consumer confusion.
- Failure to innovate, introduce, or commercialize new products in adjacent categories, such as the Beyond Immerse beverage line, could adversely affect the business.
- Changes in laws, regulations, or interpretations regarding the use of terms like 'meat' for plant-based products could impact marketing and sales.
- The company faces ongoing declines in demand for plant-based meat products and intense competition.
- The company's significant indebtedness and liabilities could limit its financial flexibility.
- The company is subject to material weaknesses in internal control over financial reporting, which have not been remediated.
- The company received a deficiency notice from Nasdaq regarding the minimum bid price requirement, which could lead to delisting if not addressed.
Future Outlook
The company expects to continue operating at a loss for the foreseeable future, focusing on reducing operating expenses, optimizing inventory, and investing in capital projects to lower production costs. They may seek additional capital through equity or debt issuance. The company is also investing in marketing, distribution infrastructure, and working capital for its brand repositioning and beverage expansion.
Management Comments
- The company has based its forward-looking statements largely on current opinions, expectations, beliefs, plans, objectives, assumptions, and projections about future events and financial trends.
- Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved.
- The company is implementing a business plan focused on achieving sustainable, profitable operations over time, including strategic initiatives to reduce operating expenses and utilize inventory management to reduce working capital.
Industry Context
StockSavvy.ai notes that Beyond Meat's performance reflects broader challenges in the plant-based meat category, including persistent demand declines and increased competition. The company's strategic pivot to 'Beyond The Plant Protein Company' and expansion into beverages like Beyond Immerse are attempts to diversify and find new growth avenues amidst these headwinds.
Legal Proceedings
- Aliments BVeggie, Inc. filed a lawsuit alleging breach of co-manufacturing agreement and seeking CAD 129.8 million in damages; the case is proceeding to arbitration in California.
- Multiple class action lawsuits were filed alleging false and misleading protein claims; a settlement agreement for $7.5 million was preliminarily approved.
- Interbev sent a cease-and-desist letter and filed a lawsuit in France alleging misleading use of terms and denigration of meat products; the company is appealing a first-instance judgment.
- A former co-manufacturer brought an arbitration action claiming at least $73.0 million in damages; the arbitrator awarded the company $13.98 million in the final award, and a settlement of $11 million was reached.
- A class action complaint was filed alleging false and misleading statements regarding asset values and impairment charges.
- A derivative stockholder action was filed against current officers and directors alleging breach of fiduciary duty and other claims, substantially similar to the class action.
- Sonate Corporation filed a trademark infringement complaint alleging infringement of its trademark 'WHERE GREAT TASTE IS PLANT-BASED'; a jury found the company liable and awarded $38.9 million in damages.
Related Party Transactions
- The company hired the son of Seth Goldman, the Chair of the Board of Directors, as Senior Manager of Community Engagement with a base salary of $130,000.
- The company's investment in TPP, a joint venture with PepsiCo, Inc., involved sales of certain products directly to the joint venture.
Stakeholder Impact
- Shareholders may experience dilution if the company raises additional capital through equity issuance or if warrants are exercised.
- The company's ongoing financial struggles and potential delisting from Nasdaq could negatively impact shareholder value.
- Customers may see changes in product availability and pricing due to strategic shifts and cost-reduction measures.
- Suppliers and co-manufacturers may be affected by the company's efforts to optimize its supply chain and potentially exit certain product lines or arrangements.
Next Steps
- Continue implementing cost-reduction initiatives and the Global Operations Review.
- Focus on gross margin expansion and cash generation.
- Execute the strategic repositioning to 'Beyond The Plant Protein Company'.
- Expand distribution of Beyond Immerse through the agreement with Big Geyser.
- Monitor and address Nasdaq's minimum bid price requirement.
Key Dates
| Date | Description |
|---|---|
| March 28, 2026 | Quarterly period end date for the filing. |
| March 29, 2025 | Prior year comparable period end date. |
| December 31, 2025 | Prior fiscal year end date. |
| April 9, 2026 | Date of filing of the 2025 10-K. |
| May 7, 2026 | Date of the filing of this Form 10-Q. |
Recommendation
holdWhile the company has shown some positive signs in gross margin improvement and expense reduction, the significant decline in revenue and continued operating losses, coupled with ongoing legal risks and potential delisting concerns, warrant a cautious approach. The strategic repositioning and new product launches offer potential but carry substantial execution risk. A 'hold' recommendation reflects the uncertainty and the need for sustained improvement before considering a more positive stance.
Keywords
Beyond Meat, 10-Q, Quarterly Report, Plant-based meat, Financial Results, Revenue, Net Loss, Cost of Goods Sold, SG&A, R&D, Beyond Immerse, Debt, Convertible Notes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.